The limitation of this study is the simplified cellular system, which allows focusing on the transactivation of HER2 by EGFR without having to consider additional crosstalk from the tumor microenvironment (TME), circulating growth factors, and the diverse functions of the immune system. The gene discussed is EGFR; the disease is neoplasm.